Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--Ouster, Inc. (Nasdaq: OUST) (“Ouster” or the “Company”), a leader in sensing and perception for Physical AI, today announced that it will report its financial results for the quarter ended June 30, 2026 after the market closes on Thursday, August 6, 2026 and host a conference call that day at 5:00 p.m. ET to discuss its results. Registration for the webcast can be completed by visiting the following website prior to, or on the day of, the conference call: https:/...

OTTAWA, Ontario & VANCOUVER, British Columbia--(BUSINESS WIRE)--BioTalent Canada et Fairleigh Dickinson University (FDU) Vancouver ont annoncé un nouveau partenariat visant à renforcer le développement de la main-d’œuvre, à approfondir l’engagement de l’industrie et à soutenir la croissance du secteur des sciences de la vie en Colombie-Britannique. Ce partenariat réunit l’expertise de BioTalent Canada en matière de développement de la main-d’œuvre en biosciences, d’intelligence du marché du tra...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that it has achieved UKCA (United Kingdom Conformity Assessed) marking for its NeXT Personal Dx test. This critical regulatory milestone enables the clinical use of Personalis’ ultrasensitive Minimal Residual Disease (MRD) detection technology across Great Britain, encompassing England, Wales, and Scotland.The UKCA marking confirms that the NeXT Personal Dx tes...

MENLO PARK, Calif.--(BUSINESS WIRE)--Arkenstone Defense, the only GovCon-native platform that equips commercial technology companies with the compliance infrastructure needed to enter the federal market, today announced that Dr. Jason Rathje has joined the company as Executive Chairman of the Board. Rathje was the founding director of the Department of War's Office of Strategic Capital (OSC), an office dedicated to attracting private investment through government lending in critical technologies...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 13.07.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,805,197.02 25.368  ...

BELLEVUE, Wash.--(BUSINESS WIRE)--Thira, creator of secure, self-learning AI system of execution built for the enterprise, today announced a $21 million seed financing led by Madrona, with participation from FUSE and a group of prominent global advisors and CIOs. Apptio co-founders Sunny Gupta and Kurt Shintaffer are reuniting as part of the founding team behind Thira. Together, with a broader founding and early team including Mudit Goel, former SVP of Engineering at Atlassian; Grant Neuman, fo...

LOS ANGELES--(BUSINESS WIRE)--Lickly, an audience-first creator intelligence platform built for data-driven brands ready to scale repeatable marketing campaigns, today announced the appointment of Nita Patel as Chief Marketing Officer.As Lickly prepares for its broader public launch in early fall, Patel will lead brand strategy, product marketing, demand generation and go-to-market execution while using the platform to build Lickly itself. The approach will put Lickly’s intelligence model to wor...

OTTAWA, Ontario & VANCOUVER, British Columbia--(BUSINESS WIRE)--BioTalent Canada and Fairleigh Dickinson University (FDU) Vancouver have announced a new partnership designed to advance workforce development, deepen industry engagement and support growth in British Columbia’s life sciences sector. The partnership brings together BioTalent Canada’s expertise in bioscience workforce development, labour market intelligence, skills development and employer engagement with FDU Vancouver’s growing foc...

NEW YORK--(BUSINESS WIRE)--Real Chemistry launched Real Chemistry ANATOMI, an ecosystem of AI solutions purpose-built to power the full healthcare commercialization lifecycle....

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourth quarter and fiscal year 2026, which ended May 31, 2026. Fiscal Year 2026 Fourth Quarter Financial Highlights     Quarter Ended May 31, 2026   Pro Forma* YoY Growth Pro Forma* N...